Yi Su
Yi Su
Banner Alzheimer's Institute
Verified email at
Cited by
Cited by
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
MR Brier, B Gordon, K Friedrichsen, J McCarthy, A Stern, J Christensen, ...
Science translational medicine 8 (338), 338ra66-338ra66, 2016
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ...
The Lancet Neurology 17 (3), 241-250, 2018
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
TLS Benzinger, T Blazey, CR Jack Jr, RA Koeppe, Y Su, C Xiong, ...
Proceedings of the National Academy of Sciences 110 (47), E4502-E4509, 2013
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
JF Arboleda-Velasquez, F Lopera, M O’Hare, S Delgado-Tirado, C Marino, ...
Nature medicine 25 (11), 1680-1683, 2019
Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between β-amyloid and tauopathy
L Wang, TL Benzinger, Y Su, J Christensen, K Friedrichsen, P Aldea, ...
JAMA neurology 73 (9), 1070-1077, 2016
Loss of brain aerobic glycolysis in normal human aging
MS Goyal, AG Vlassenko, TM Blazey, Y Su, LE Couture, TJ Durbin, ...
Cell metabolism 26 (2), 353-360. e3, 2017
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
BA Gordon, K Friedrichsen, M Brier, T Blazey, Y Su, J Christensen, ...
Brain 139 (8), 2249-2260, 2016
Partial volume correction in quantitative amyloid imaging
Y Su, TM Blazey, AZ Snyder, ME Raichle, DS Marcus, BM Ances, ...
Neuroimage 107, 55-64, 2015
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
EM Reiman, JF Arboleda-Velasquez, YT Quiroz, MJ Huentelman, ...
Nature communications 11 (1), 1-11, 2020
Quantitative analysis of PiB-PET with freesurfer ROIs
Y Su, GM D'Angelo, AG Vlassenko, G Zhou, AZ Snyder, DS Marcus, ...
PloS one 8 (11), e73377, 2013
A novel PET tumor delineation method based on adaptive region‐growing and dual‐front active contours
H Li, WL Thorstad, KJ Biehl, R Laforest, Y Su, KI Shoghi, ED Donnelly, ...
Medical physics 35 (8), 3711-3721, 2008
Morning-evening variation in human brain metabolism and memory circuits
BJ Shannon, RA Dosenbach, Y Su, AG Vlassenko, LJ Larson-Prior, ...
Journal of neurophysiology 109 (5), 1444-1456, 2013
Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers
BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ...
Brain 142 (4), 1063-1076, 2019
Persistent metabolic youth in the aging female brain
MS Goyal, TM Blazey, Y Su, LE Couture, TJ Durbin, RJ Bateman, ...
Proceedings of the National Academy of Sciences 116 (8), 3251-3255, 2019
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure
S Mishra, BA Gordon, Y Su, J Christensen, K Friedrichsen, K Jackson, ...
Neuroimage 161, 171-178, 2017
Longitudinal β-amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non–Alzheimer disease pathophysiology
BA Gordon, T Blazey, Y Su, AM Fagan, DM Holtzman, JC Morris, ...
JAMA neurology 73 (10), 1192-1200, 2016
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
SJB Vos, BA Gordon, Y Su, PJ Visser, DM Holtzman, JC Morris, ...
Neurobiology of aging 44, 1-8, 2016
MR-based attenuation correction for PET/MRI neurological studies with continuous-valued attenuation coefficients for bone through a conversion from R2* to CT-Hounsfield units
MR Juttukonda, BG Mersereau, Y Chen, Y Su, BG Rubin, TLS Benzinger, ...
Neuroimage 112, 160-168, 2015
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
AG Vlassenko, L McCue, MS Jasielec, Y Su, BA Gordon, C Xiong, ...
Annals of neurology 80 (3), 379-387, 2016
The system can't perform the operation now. Try again later.
Articles 1–20